Advertisement

Digestive Diseases and Sciences

, Volume 58, Issue 3, pp 751–758 | Cite as

Pre-S Mutation Is a Significant Risk Factor for Hepatocellular Carcinoma Development: A Long-Term Retrospective Cohort Study

  • Dong Hyun Sinn
  • Moon Seok Choi
  • Geum-Youn Gwak
  • Yong-Han Paik
  • Joon Hyeok Lee
  • Kwang Cheol Koh
  • Seung Woon Paik
  • Byung Chul Yoo
Original Article

Abstract

Background

Several cross-sectional studies have shown an association between pre-S mutation and hepatocellular carcinoma (HCC).

Aims

We aim to verify whether pre-S mutation represents a risk for HCC development in a longitudinal way.

Methods

A total of 195 patients with chronic HBV infection [age: 43.7 ± 10.8 years, males: 141 (72.3 %), genotype C: 195 (100 %), hepatitis B e antigen (HBeAg) positive: 109 (55.9 %), cirrhosis: 79 (40.5 %), and pre-S mutation positive: 44 (22.6 %)] were followed up for a median of 7.2 years (range 1.0–7.8 years).

Results

HCC developed in 24 patients during follow-up. The 1-, 3-, and 5-year cumulative incidences of HCC were 0.5, 4.9, and 10.4 %, respectively. Patients with pre-S mutation had significantly higher 5-year cumulative incidences of HCC than those without (26.5 vs. 5.7 %, p < 0.001) and showed higher hazard ratio for HCC [3.04 (95 % CI 1.24–7.42), p = 0.015, adjusted for age, gender, HBeAg, cirrhosis and baseline HBV DNA level]. Notably, in patients aged ≥50 years, the 5-year cumulative incidences of HCC in patients with pre-S mutation were considerably high (58.3 %), compared to those without (16.1 %, p < 0.001).

Conclusions

Patients with pre-S mutations had higher incidence of HCC during follow-up, especially in aged patients. Patients with pre-S mutations, especially older ones, may require careful attention to HCC development.

Keywords

Hepatocellular carcinoma Pre-S mutation Risk Hepatitis B 

Abbreviations

HBV

Hepatitis B virus

HBsAg

Hepatitis B surface antigen

HCC

Hepatocellular carcinoma

PCR

Polymerase chain reaction

AFP

Alpha-fetoprotein

ROC

Receiver operator curve

OR

Odd ratios

ER

Endoplasmic reticulum

Notes

Conflict of interest

None.

References

  1. 1.
    Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature. 1985;317:489–495.PubMedCrossRefGoogle Scholar
  2. 2.
    Berthelot P, Neurath R, Courouce AM, et al. Hepatitis B vaccines with pre-S gene product. Lancet. 1986;1:1150.PubMedCrossRefGoogle Scholar
  3. 3.
    Neurath AR, Adamowicz P, Kent SB, et al. Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein. Mol Immunol. 1986;23:991–997.PubMedCrossRefGoogle Scholar
  4. 4.
    Milich DR, McNamara MK, McLachlan A, Thornton GB, Chisari FV. Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region. Proc Natl Acad Sci USA. 1985;82:8168–8172.PubMedCrossRefGoogle Scholar
  5. 5.
    Milich DR, Thornton GB, Neurath AR, et al. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science. 1985;228:1195–1199.PubMedCrossRefGoogle Scholar
  6. 6.
    Hunt CM, McGill JM, Allen MI, Condreay LD. Clinical relevance of hepatitis B viral mutations. Hepatology. 2000;31:1037–1044.PubMedCrossRefGoogle Scholar
  7. 7.
    Kao JH. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatol Int. 2007;1:415–430.PubMedCrossRefGoogle Scholar
  8. 8.
    Yamamoto K, Horikita M, Tsuda F, et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol. 1994;68:2671–2676.PubMedGoogle Scholar
  9. 9.
    Choi MS, Kim DY, Lee DH, et al. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat. 2007;14:161–168.PubMedCrossRefGoogle Scholar
  10. 10.
    Cao Z, Bai X, Guo X, Jin Y, Qian G, Tu H. High prevalence of hepatitis B virus pre-S mutation and its association with hepatocellular carcinoma in Qidong, China. Arch Virol. 2008;153:1807–1812.PubMedCrossRefGoogle Scholar
  11. 11.
    Wang HC, Huang W, Lai MD, Su IJ. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci. 2006;97:683–688.PubMedCrossRefGoogle Scholar
  12. 12.
    Chen CF, Lee WC, Yang HI, et al. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Gastroenterology. 2011;141:1240–1248.Google Scholar
  13. 13.
    Chen CH, Hung CH, Lee CM, et al. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology. 2007;133:1466–1474.PubMedCrossRefGoogle Scholar
  14. 14.
    Park JW. Practice guideline for diagnosis and treatment of hepatocellular carcinoma. Korean J Hepatol. 2004;10:88–98.PubMedGoogle Scholar
  15. 15.
    Qu LS, Liu TT, Jin F, et al. Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: a nested case-control study in China. Hepatol Res. 2011;41:54–63.PubMedCrossRefGoogle Scholar
  16. 16.
    Yeung P, Wong DK, Lai CL, Fung J, Seto WK, Yuen MF. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B. J Infect Dis. 2011;203:646–654.PubMedCrossRefGoogle Scholar
  17. 17.
    Chen CH, Changchien CS, Lee CM, et al. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J Infect Dis. 2008;198:1634–1642.PubMedCrossRefGoogle Scholar
  18. 18.
    Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology. 2006;130:1153–1168.PubMedCrossRefGoogle Scholar
  19. 19.
    Lin CL, Liu CH, Chen W, et al. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22:1098–1103.PubMedCrossRefGoogle Scholar
  20. 20.
    Abe K, Thung SN, Wu HC, et al. Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children. Cancer Sci. 2009;100:2249–2254.PubMedCrossRefGoogle Scholar
  21. 21.
    Hildt E, Munz B, Saher G, Reifenberg K, Hofschneider PH. The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J. 2002;21:525–535.PubMedCrossRefGoogle Scholar
  22. 22.
    Hung JH, Su IJ, Lei HY, et al. Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp 38 mitogen-activated protein kinase. J Biol Chem. 2004;279:46384–46392.PubMedCrossRefGoogle Scholar
  23. 23.
    Wang HC, Chang WT, Chang WW, et al. Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes. Hepatology. 2005;41:761–770.PubMedCrossRefGoogle Scholar
  24. 24.
    Tai PC, Suk FM, Gerlich WH, Neurath AR, Shih C. Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants. Virology. 2002;292:44–58.PubMedCrossRefGoogle Scholar
  25. 25.
    Wang HC, Wu HC, Chen CF, Fausto N, Lei HY, Su IJ. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol. 2003;163:2441–2449.PubMedCrossRefGoogle Scholar
  26. 26.
    Hsieh YH, Su IJ, Wang HC, et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis. 2004;25:2023–2032.PubMedCrossRefGoogle Scholar
  27. 27.
    Benz CC, Yau C. Ageing, oxidative stress and cancer: paradigms in parallax. Nat Rev Cancer. 2008;8:875–879.PubMedCrossRefGoogle Scholar
  28. 28.
    Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022.PubMedCrossRefGoogle Scholar
  29. 29.
    Kao JH, Chen PJ, Lai MY, Chen DS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology. 2003;124:327–334.PubMedCrossRefGoogle Scholar
  30. 30.
    Huy TT, Ushijima H, Win KM, et al. High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbiol. 2003;41:5449–5455.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Dong Hyun Sinn
    • 1
    • 2
  • Moon Seok Choi
    • 1
  • Geum-Youn Gwak
    • 1
  • Yong-Han Paik
    • 1
  • Joon Hyeok Lee
    • 1
  • Kwang Cheol Koh
    • 1
  • Seung Woon Paik
    • 1
  • Byung Chul Yoo
    • 1
  1. 1.Department of Medicine, Samsung Medical CenterSungkyunkwan University School of MedicineSeoulSouth Korea
  2. 2.Department of Medicine, Sanggye Paik HospitalInje University School of MedicineSeoulSouth Korea

Personalised recommendations